NYMX

Nymox Pharmaceutical Corporation (NYMX) | Rumor.io

Nymox Pharmaceutical

NYMX

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about NYMX?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% +0	0% +0	0% +0	0% 0

Dec 8

Nymox Pharmaceutical Corporation's stock price has increased by 23% since the previous trading day close, currently trading at $0.61.
The stock has seen a significant surge in volume, with 266% above average volume.
The company has experienced a high call volume, with 8.2K% of the 30-day average call volume.

Generated by AI

Sentiment

Of the messages about NYMX that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	100% +10.53
Bearish	—	—	—	0% -10.53

Bullish· Oct 11

NYMX has shown impressive durability in a recent study, indicating potential long-term growth.
The company has experienced significant volatility since July, but long-term investors may see a short squeeze as a buying opportunity.
NYMX is a strong candidate for a long trade setup, with potential for a price increase to $6, driven by positive phase 3 news and FDA trials.

Bearish· Aug 26

The initial run of $NYMX was not due to fundamentals, but rather a short squeeze.
The stock's recent drop may be setting up for a second, potentially larger decline.
$NYMX has a history of failing to sustain large gains on earnings days, suggesting a bearish trade.

Generated by AI

Topics

Of the messages about NYMX that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	100%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	0%

Dec 5

Nymox Pharmaceutical Corporation announced that EVSX, a subsidiary of Secura BioSciences, has secured a location for a battery recycling facility in Ontario.
Nymox Pharmaceutical Corporation was mentioned in a breaking news announcement about 1812 Brewing Company's e-commerce agreement to sell its beer in 45 states and Washington D.C.
Nymox Pharmaceutical Corporation was mentioned in a breaking news announcement about Rockley Photonics' CEO speaking at the Commonwealth Trade and Investment Summit 2022.

Generated by AI

Community

Of the messages about NYMX, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	100%	100%	100%
Newcomers	0%	0%	0%	0%

Regulars· Dec 8

Nymox Pharmaceutical Corporation's call volume has increased significantly, with 676 calls made, representing 8.2K% of the 30-day average call volume, indicating potential investor interest.
Nymox Pharmaceutical Corporation's stock price has surged, increasing by $0.02 (5.01%) and now trading at $0.52.
Regular investors are actively buying the dip in Nymox Pharmaceutical Corporation's stock, with many hoarding shares, suggesting a strong market presence.

Newcomers· Dec 5

The $NYMX stock has seen an increase in trading volume this month, possibly due to the release of new marketing materials for NYMOZARFEX, a treatment for BPH.
The stock price of $NYMX has surged 77% in a single day, with a 2309% increase in relative volume, causing the shares to trade at $0.51.
$NYMX is considered a medium float stock, and its recent price movement may be worth monitoring for potential trading opportunities.

Generated by AI

Also Discussed

Investors talking about NYMX also mention

#	Name	Attention
1	XOMA CorporationXOMA	0%0
2	VBLT - Vascular Biogenics Ltd.	——
3	BCEI - Civitas Resources, Inc.	——
4	Can-Fite BioPharma Ltd. ADRCANF	0%0
5	REPH - Recro Pharma, Inc.	——
6	NAVB - Navidea Biopharmaceuticals, Inc.	——
7	Net Element IncNETE	0%0
8	Vericel CorporationVCEL	0%0
9	B.O.S. Better Online Solutions Ltd.BOSC	0%0
10	PFIE - Profire Energy, Inc.	——